World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
51248
World Ranking
3243
National Ranking
120

Rob Pieters publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rob Pieters sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 877 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rob Pieters D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rob Pieters sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rob Pieters is affiliated with the Princess Máxima Center in the Netherlands. Their research primarily spans the field of Medicine, with a substantial focus on subfields such as Public Health, Environmental and Occupational Health; Pediatrics, Perinatology and Child Health; Hematology; Molecular Biology; and Oncology.

Their work addresses several key topics including:

  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • CAR-T cell therapy research
  • Adolescent and Pediatric Healthcare

Rob Pieters has contributed to numerous publications, with a notable presence in these publication venues:

  • Blood
  • European Journal of Cancer
  • Leukemia
  • Journal of Clinical Oncology
  • Haematologica

Frequent co-authors working alongside Rob Pieters include Inge M. van der Sluis, Gabriele Escherich, Marta Fiocco, Andishe Attarbaschi, and Marry M. van den Heuvel-Eibrink, with collaboration counts ranging from 17 to 27 papers each.

Among Pieters' recent papers are:

  • Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment, 2020, European Journal of Cancer
  • Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia, 2023, New England Journal of Medicine
  • T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies, 2020, Blood Cancer Discovery
  • Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia, 2020, Journal of Clinical Oncology
  • Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia, 2022, Blood Advances

Best Publications

  • Mll translocations specify a distinct gene expression profile, distinguishing a unique leukemia

    Todd R. Golub;Scott A. Armstrong;Stanley J. Korsmeyer

  • A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

    Monique L Den Boer;Marjon van Slegtenhorst;Renée X De Menezes;Renée X De Menezes;Meyling H Cheok

  • Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

    Ching Hon Pui;Jun J. Yang;Stephen P. Hunger;Rob Pieters

  • FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

    Jennifer O'Neil;Jonathan Grim;Peter Strack;Sudhir Rao

  • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

    Rob Pieters;Martin Schrappe;Paola De Lorenzo;Ian Hann

  • Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment

    Amy Holleman;Meyling H Cheok;Monique L den Boer;Wenjian Yang

  • L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

    Rob Pieters;Stephen P. Hunger;Joachim Boos;Carmelo Rizzari

  • Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

    Guo Wei;Guo Wei;David Twomey;David Twomey;Justin Lamb;Krysta Schlis

  • Biological and therapeutic aspects of infant leukemia

    Andrea Biondi;Giuseppe Cimino;Rob Pieters;Ching-Hon Pui

  • Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification

    Scott A Armstrong;Andrew L Kung;Andrew L Kung;Meghann E Mabon;Lewis B Silverman;Lewis B Silverman

  • Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

    Priscila P. Zenatti;Daniel Ribeiro;Wenqing Li;Linda Zuurbier

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer

  • Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

    Irene Homminga;Rob Pieters;Anton W. Langerak;Johan J. de Rooi

  • Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

    Andrea Biondi;Martin Schrappe;Paola De Lorenzo;Anders Castor

  • Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

    Rob Pieters;Hester A. de Groot-Kruseman;Vincent van der Velden;Marta Fiocco

  • PHF6 mutations in T-cell acute lymphoblastic leukemia

    Pieter van Vlierberghe;Pieter van Vlierberghe;Pieter van Vlierberghe;Teresa Palomero;Hossein Khiabanian;Joni van der Meulen

  • In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties

    Christoph le Viseur;Marc Hotfilder;Simon Bomken;Kerrie Wilson

  • NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

    Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

Frequent Co-Authors

Marry M. van den Heuvel-Eibrink
Marry M. van den Heuvel-Eibrink University Medical Center Utrecht
Dirk Reinhardt
Dirk Reinhardt University of Duisburg-Essen
Maria Grazia Valsecchi
Maria Grazia Valsecchi University of Milano-Bicocca
H. Berna Beverloo
H. Berna Beverloo Erasmus University Rotterdam
André Baruchel
André Baruchel Hôpital Robert-Debré
Martin Schrappe
Martin Schrappe Kiel University
Martin Zimmermann
Martin Zimmermann Hannover Medical School
Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Jan Trka
Jan Trka Charles University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in a medical career but looking for alternative study options or flexible pathways? Today, students can access a range of accredited healthcare programs entirely online, paving the way to dynamic roles in the medical field.

For those still in high school or exploring early college credit, the best online schools for high school students offer a head start in healthcare studies. These programs provide foundational courses and skills for an early launch into medical careers.

Fast-growing fields like health administration offer additional entry points. Specialized courses in online medical billing and coding allow students to quickly upskill and enter vital support roles in medical offices and hospitals.

Nursing is another popular path for those seeking in-demand healthcare roles. Options like a cheapest online nurse practitioner programs and a nursing degree online make it possible to balance studies with work or family.

Exploring related online degrees and innovative pathways can open doors to rewarding medical careers beyond the traditional MD route in the USA.

Best Scientists Citing Rob Pieters

Trending Scientists

Recently Published Articles